Vasodilator Agents Protect against Indinavir Nephrotoxicity

Abstract

Indinavir (IDV) is a protease inhibitor widely used in AIDS treatment. A sustained elevation of creatinine was identified in IDV-treated patients. We have previously demonstrated that IDV causes renal vasoconstriction in rats. The objective of this study was to investigate the mechanism of IDV-induced vasoconstriction and the effect that the vasodilator agents L-arginine (LA), nifedipine (NF), as well as magnesium supplementation (Mg), have on IDV-induced nephrotoxicity. Male Wistar rats were kept on fast overnight and given free access to water. IDV (80 mg/kg BW) and NF (3 mg/kg BW) were given by gavage for 15 days. LA (1.5%) and MgCl2.6H2O (1%) were added to drinking water. Six groups were studied: Control ( n=6): normal rats treated with vehicle, a 0.05 M citric acid solution; IDV ( n=7): IDV-treated rats; IDV+LA ( n=6): IDV- and LA-treated rats; IDV+NF ( n=7): IDV- and NF-treated rats; IDV+Mg ( n=7): IDV- and MgCl2-treated rats; IDV+Mg+L-NAME ( n=9): IDV- and MgCl2-treated rats, supplemented with L-NAME (2.5 mg/l in drinking water). Clearance studies and evaluations of urinary nitrite (NO2) excretion were performed on day 16. No changes in blood pressure were observed. NO2 excretion decreased in IDV-treated rats. LA and NF protected against IDV effects, improving GFR (IDV+LA, 1.95 ±0.10; IDV+NF, 1.94 ±0.07 vs IDV, 1.15 ±0.07 ml/min, P<0.001) and RBF (IDV+LA, 7.83 ±0.09; IDV+NF, 7.63 ±0.14 vs IDV, 6.17 ±0.25 ml/min, P<0.001). These results suggest that IDV-induced vasoconstriction is mediated by NO and Ca2+ channels. Magnesium also ameliorated GFR and RBF in IDV-treated rats (GFR IDV+Mg, 1.77 ±0.08 ml/min, P<0.001; RBF IDV+Mg, 7.35 ±0.158 ml/min, P<0.001). Magnesium protection is not NO-mediated since it was not blocked by L-NAME. In conclusion, LA, NF and Mg protect against IDV-induced nephrotoxicity in rats. This study may have potential clinical implications for prevention of IDV-induced nephrotoxicity.